Retraction

TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide

Citations (4)

4
Total Citations
2
Post-Retraction
(50.0%)
0
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
2 Within 1 year
0 After 2+ years
56 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
<scp>TTC7B</scp> is a new prognostic biomarker in head and neck squamous cell carcinoma linked to immune infiltration and ferroptosis
Rong He, Xun Zhang, Yongzhi Wu et al. (5 authors)
Cancer Medicine Open Access
Published: Nov 2023
2 citations
56 days after retraction
BCL2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas
Lun Gao, Zhang Ye, Shu Peng et al. (12 authors)
Aging Open Access
Published: Oct 2023
5 citations
28 days after retraction
Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide
Oxidative Medicine And Cellular Longevity
Oxidative Medicine and Cellular Longevity Open Access
Published: Sep 2023
Same day as retraction
Quick Stats
Total Citations: 6
Years Since Retraction: 2.1 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Clinical Effect of Digital Subtraction Angiography Combined…
Oxidative Medicine and Cellular Longevity • 9 citations
Combined Association of Low-Density Lipoprotein Cholesterol…
Oxidative Medicine and Cellular Longevity • 6 citations
Microglia Involves in the Immune Inflammatory Response of P…
Oxidative Medicine and Cellular Longevity • 8 citations
Mesenchymal Stem Cell-Derived Exosomes and Their Potential …
Oxidative Medicine and Cellular Longevity • 21 citations
Capsaicin Alleviates Vascular Endothelial Dysfunction and C…
Oxidative Medicine and Cellular Longevity • 18 citations